Read More 24 minute read Options Stocks That Hit 52-Week Lows On Monday By Benzinga Insights Today, 5:26 PM On Monday, 429 stocks made new 52-week lows. ADCT
Read More 29 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 5:26 PM During Friday's session, 574 stocks hit new 52-week lows. ACCO
Read More 13 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Tuesday By Benzinga Insights Today, 5:26 PM On Tuesday, 250 stocks hit new 52-week lows. ACHV
Read More 11 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Monday By Benzinga Insights Today, 5:26 PM On Monday, 195 stocks hit new 52-week lows. ACHV
Read More 5 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights Today, 5:26 PM During Thursday's trading, 62 companies set new 52-week lows. AGFY
Read More 4 minute read Biotech General Health Care Penny Stocks Small Cap Recap Of Monday’s Biotech Catalysts – End Of the Day Summary By Ragothaman Srinivasan Today, 5:26 PM Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy… ANIX
Read More 1 minute read FDA General Health Care News Penny Stocks Small Cap FDA Clears Organogenesis’ Next Generation PuraPly Surgical Solution By Vandana Singh Today, 5:26 PM Organogenesis Holdings Inc (NASDAQ:ORGO) has received the FDA 510k Clearance for PuraPly MZ, a brand extension to the PuraPly product portfolio. … ORGO
Read More 8 minute read Markets Movers News Penny Stocks Pre-Market Outlook Small Cap Trading Ideas Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday By Lisa Levin Today, 5:26 PM Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. ABCL
Read More 1 minute read Biotech Earnings General Guidance Health Care Movers News Penny Stocks Small Cap Trading Ideas Organogenesis’ Q2 Operating Income Fell 50%, Lowers Annual Guidance By Vandana Singh Today, 5:26 PM Organogenesis Holdings Inc’s (NASDAQ:ORGO) Q2 FY22 sales reached $121.4 million, down 1% Y/Y, slightly ahead of the consensus of $120.90… ORGO
Read More 1 minute read Earnings Recap: Organogenesis Q2 Earnings By Benzinga Insights Today, 5:26 PM Organogenesis Hldgs (NASDAQ:ORGO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. ORGO